JelloX Biotech Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
JelloX Biotech General Information
Description
Developer of a digital pathology imaging and analysis platform designed for generating and interpreting three-dimensional tissue images for medical diagnosis. The company's platform offers high-resolution three-dimensional tissue imaging, artificial intelligence-enhanced analysis software, digital slide viewing tools, and quantitative feature extraction services, enabling healthcare and research professionals to improve diagnostic accuracy, comprehensive tissue assessment, and more informed clinical decision-making in pathology and precision medicine.
Contact Information
Website
www.jellox.comCorporate Office
- Number 66-5, Shengyi 5th Road
- Hsinchu County
- Zhubei, 300-13
- Taiwan
Corporate Office
- Number 66-5, Shengyi 5th Road
- Hsinchu County
- Zhubei, 300-13
- Taiwan
JelloX Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 04-Jun-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 03-Jun-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 14-Nov-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
JelloX Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
JelloX Biotech Patents
JelloX Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250252572-A1 | Method, system, and computer-readable recording media for processing tissue images | Pending | 06-Feb-2024 | ||
| JP-2025121373-A | Tissue imaging processing method, system, and computer-readable recording medium | Active | 06-Feb-2024 | ||
| US-20240167920-A1 | Composition and method for three-dimensional histological staining | Pending | 17-Nov-2022 | ||
| US-20220357246-A1 | Composition and method for rendering biological material | Pending | 07-Aug-2019 | ||
| WO-2021023289-A1 | Composition and method for rendering biological material | Inactive | 07-Aug-2019 | G01N1/30 |
JelloX Biotech Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Accelerator | Accelerator/Incubator | |||
| UC Berkeley School of Public Health Innovation Accelerator Program | Accelerator/Incubator | |||
| RAPID-Health | Accelerator/Incubator | |||
| International Biomedical Intelligence Accelarator | Accelerator/Incubator | |||
| Industry Accelerator and Patent Strategy | Accelerator/Incubator |
JelloX Biotech FAQs
-
When was JelloX Biotech founded?
JelloX Biotech was founded in 2018.
-
Where is JelloX Biotech headquartered?
JelloX Biotech is headquartered in Zhubei, Taiwan.
-
What industry is JelloX Biotech in?
JelloX Biotech’s primary industry is Other Healthcare Technology Systems.
-
Is JelloX Biotech a private or public company?
JelloX Biotech is a Private company.
-
What is JelloX Biotech’s current revenue?
The current revenue for JelloX Biotech is .
-
Who are JelloX Biotech’s investors?
MedTech Accelerator, UC Berkeley School of Public Health Innovation Accelerator Program, RAPID-Health, International Biomedical Intelligence Accelarator, and Industry Accelerator and Patent Strategy are 5 of 6 investors who have invested in JelloX Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
